Company intelligence / Profile preview

Huiling Pharmaceutical Consulting

Shanghai, Shanghai, China

Ownership: Private
Development stage: Other

Overview

Huiling Pharmaceutical Consulting is a specialized regulatory and clinical service provider based in Shanghai, China. The firm provides comprehensive support for pharmaceutical and biotechnology companies seeking to navigate the complex Chinese regulatory landscape, specifically focusing on NMPA (formerly CFDA) submissions. Their service portfolio includes IND and NDA filings, clinical trial design, GCP compliance auditing, and pharmacovigilance. Huiling acts as a strategic partner for international firms looking to enter the Chinese market and for domestic companies aiming to meet global regulatory standards.

Industry: Consulting

Beyond the preview

Go deeper on Huiling Pharmaceutical Consulting.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Huiling Pharmaceutical Consulting.

Explore the full profile